reSee.it Podcast Summary
Bret Weinstein and Joe Rogan discuss the urgent need for an emergency podcast regarding COVID-19 treatments, particularly focusing on ivermectin. Dr. Pierre Kory, a lung and ICU specialist, introduces himself as part of a group that developed treatment protocols for COVID-19, emphasizing their expertise in ivermectin's use against the virus.
Weinstein shares his background as an evolutionary biologist and how he and his wife, Heather, began analyzing COVID-19 data early in the pandemic. They encountered evidence suggesting ivermectin's effectiveness, which led to their discussions and research on the topic.
Dr. Kory explains that their group, the Frontline COVID-19 Critical Care Alliance, was formed to create treatment protocols based on extensive research. He mentions initial studies showing ivermectin's efficacy in cell cultures, which prompted some regions to use it clinically despite the lack of human trials at that time.
The conversation shifts to the censorship faced by Weinstein and Kory on platforms like YouTube, where their discussions about ivermectin have led to strikes and video removals. They highlight the inconsistency in guidelines from health organizations like the CDC and WHO regarding treatments and vaccinations, particularly around the use of remdesivir and the evolving understanding of airborne transmission of the virus.
Dr. Kory points out the disparity between the WHO's recommendations and the evidence supporting ivermectin, noting that the drug is inexpensive and widely available, unlike newer, patented treatments. They express concern over the influence of pharmaceutical companies on treatment guidelines and the potential for profit-driven motives to overshadow public health.
Weinstein emphasizes the importance of open discussion in science, arguing that censorship prevents the sharing of critical information that could save lives. They discuss the implications of ignoring effective treatments like ivermectin, particularly in the context of the ongoing pandemic and the need for early intervention.
Dr. Kory shares success stories from countries like Mexico and India, where ivermectin has been used effectively to reduce hospitalization and death rates. They stress the need for a coordinated approach to treatment that includes ivermectin and other repurposed drugs.
The discussion concludes with a call for transparency and the importance of allowing scientific discourse to flourish without censorship. They express hope that the evidence supporting ivermectin will eventually lead to its broader acceptance and use in treating COVID-19.